Drug Shortage Report for MAR-ROSUVASTATIN
Report ID | 224359 |
Drug Identification Number | 02413108 |
Brand name | MAR-ROSUVASTATIN |
Common or Proper name | ROSUVASTATIN |
Company Name | MARCAN PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | ROSUVASTATIN |
Strength(s) | 40MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C10AA |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2024-04-05 |
Estimated end date | 2024-08-30 |
Actual end date | 2024-07-31 |
Shortage status | Resolved |
Updated date | 2024-08-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2024-08-01 | English | Compare |
v11 | 2024-07-31 | French | Compare |
v10 | 2024-07-31 | English | Compare |
v9 | 2024-07-31 | French | Compare |
v8 | 2024-07-31 | English | Compare |
v7 | 2024-07-08 | French | Compare |
v6 | 2024-07-08 | English | Compare |
v5 | 2024-06-10 | French | Compare |
v4 | 2024-06-10 | English | Compare |
v3 | 2024-04-06 | English | Compare |
v2 | 2024-04-05 | French | Compare |
v1 | 2024-04-05 | English | Compare |
Showing 1 to 12 of 12